EtiraRx
PrivateLast Round
Accelerator
Apr 14, 2026
Total Funding Raised
$3.42M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EtiraRx is a biopharmaceutical company that develops novel cancer therapeutics to treat cancers by validating molecular drivers and evaluating mechanisms of therapy resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EtiraRx Comparables
Compare EtiraRx with similar companies based on industry and business-model similarity.
EtiraRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 14, 2026 | ||||
| Seed | Oct 4, 2023 | ||||
| Grant | Aug 15, 2021 |
EtiraRx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| MassChallenge Israel | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
Received funding from MassChallenge.
- Nov 10, 2025
Monthly visitors increased 62% MoM.
EtiraRx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about EtiraRx's valuation, stock price, and market status.
Is EtiraRx a public or private company?
EtiraRx is a private company.
What is the current stock price of EtiraRx?
EtiraRx is a private company with no public stock price. No recent secondary market data is available.
How much is EtiraRx worth (valuation)?
Valuation information for EtiraRx is not publicly available.
Can I buy EtiraRx stock?
EtiraRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was EtiraRx's last funding round?
EtiraRx's most recent funding round was Accelerator on April 14, 2026.
Who are the main investors in EtiraRx?
Key investors in EtiraRx include National Cancer Institute, MassChallenge.
Will EtiraRx IPO soon?
No public IPO plans have been announced for EtiraRx.
How can I track EtiraRx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EtiraRx's secondary market activity and sign up for updates.